Literature DB >> 16830087

Superior vena cava and innominate vein dimensions in growing children : an aid for interventional devices and transvenous leads.

Sanjeev Sanjeev1, Peter P Karpawich.   

Abstract

Transvenous (TV) pacing and defibrillation leads are frequently implanted in children as part of treatment for various congenital and acquired rhythm abnormalities. However, the lead-vascular endothelial interaction is not a benign process and is associated with a risk of progressive venous obstruction. Often, this obstruction requires surgical or interventional relief. The risk of obstruction is related to venous diameters at implant and lead size. Since venous diameters are largely unknown at different ages, the purpose of this study was to correlate innominate vein (INN) and superior vena cava (SVC) diameters with body dimensions in growing children.

Entities:  

Mesh:

Year:  2006        PMID: 16830087     DOI: 10.1007/s00246-006-1133-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

1.  Risk factors for venous obstruction in children with transvenous pacing leads.

Authors:  F H Figa; B W McCrindle; J L Bigras; R M Hamilton; R M Gow
Journal:  Pacing Clin Electrophysiol       Date:  1997-08       Impact factor: 1.976

2.  Great vessel, cardiac chamber, and wall growth patterns in normal children.

Authors:  M L Epstein; S J Goldberg; H D Allen; L Konecke; J Wood
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

3.  Short-term thrombosis after transvenous permanent pacemaker insertion.

Authors:  D Antonelli; Y Turgeman; Z Kaveh; S Artoul; T Rosenfeld
Journal:  Pacing Clin Electrophysiol       Date:  1989-02       Impact factor: 1.976

4.  Pediatric transvenous pacing: a concern for venous thrombosis?

Authors:  P C Gillette; V Zeigler; G B Bradham; P Kinsella
Journal:  Pacing Clin Electrophysiol       Date:  1988-11       Impact factor: 1.976

5.  Transvenous pacemakers in children: relation of lead length to anticipated growth.

Authors:  A Gheissari; A J Hordof; H M Spotnitz
Journal:  Ann Thorac Surg       Date:  1991-07       Impact factor: 4.330

6.  Endocardial pacemakers in children: lead length and allowance for growth.

Authors:  J J O'Sullivan; S Jameson; R G Gold; C Wren
Journal:  Pacing Clin Electrophysiol       Date:  1993-02       Impact factor: 1.976

Review 7.  Venous complications after insertion of a transvenous pacemaker.

Authors:  P C Spittell; D L Hayes
Journal:  Mayo Clin Proc       Date:  1992-03       Impact factor: 7.616

8.  Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the fontan procedure.

Authors:  Maully J Shah; Rodrigo Nehgme; Michael Carboni; John D Murphy
Journal:  Pacing Clin Electrophysiol       Date:  2004-07       Impact factor: 1.976

9.  Long-term transvenous pacing in children weighing ten kilograms or less.

Authors:  D E Ward; S Jones; E A Shinebourne
Journal:  Int J Cardiol       Date:  1987-04       Impact factor: 4.164

Review 10.  Pacemaker-induced superior vena cava syndrome: report of four cases and review of the literature.

Authors:  J A Goudevenos; P G Reid; P C Adams; M P Holden; D O Williams
Journal:  Pacing Clin Electrophysiol       Date:  1989-12       Impact factor: 1.976

View more
  3 in total

Review 1.  Pacing device therapy in infants and children: a review.

Authors:  Daiji Takeuchi; Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-10-27       Impact factor: 1.731

2.  Normative MDCT cross-sectional data estimation of superior vena cava and innominate vein in growing children using age as a predictor.

Authors:  Karuna M Das; Tariq S Momenah; Rajvir Singh; Shanker Raja; Abdulrahman AlMoukirish; Mohammad AlZoum; Sven G Larsson
Journal:  Pediatr Cardiol       Date:  2014-03-20       Impact factor: 1.655

3.  Case series of late lead dislodgement of Medtronic SelectSecure 3830 pacing leads in growing paediatric patients.

Authors:  Li Yen Ng; Sarah Gallagher; Kevin P Walsh
Journal:  Eur Heart J Case Rep       Date:  2021-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.